Cancer of unknown primary: Biological and clinical characteristics
dc.contributor.author | Pavlidis, Nicholas | en |
dc.creator | Pavlidis, Nicholas | en |
dc.date.accessioned | 2018-06-22T09:54:15Z | |
dc.date.available | 2018-06-22T09:54:15Z | |
dc.date.issued | 2003 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42269 | |
dc.language.iso | eng | en |
dc.source | Annals of Oncology | en |
dc.subject | Adult | en |
dc.subject | Antineoplastic agent | en |
dc.subject | Bleomycin | en |
dc.subject | Cisplatin | en |
dc.subject | Cyclophosphamide | en |
dc.subject | Doxorubicin | en |
dc.subject | Etoposide | en |
dc.subject | Fluorouracil | en |
dc.subject | Human | en |
dc.subject | Neoplasms | en |
dc.subject | Vinblastine | en |
dc.subject | Aged | en |
dc.subject | Humans | en |
dc.subject | Female | en |
dc.subject | Mammography | en |
dc.subject | Middle aged | en |
dc.subject | Cancer combination chemotherapy | en |
dc.subject | Carboplatin | en |
dc.subject | Computer assisted tomography | en |
dc.subject | Platinum derivative | en |
dc.subject | Priority journal | en |
dc.subject | Prognosis | en |
dc.subject | Gemcitabine | en |
dc.subject | Taxane derivative | en |
dc.subject | Cancer staging | en |
dc.subject | Review | en |
dc.subject | Cancer mortality | en |
dc.subject | Alpha interferon | en |
dc.subject | Unindexed drug | en |
dc.subject | Epirubicin | en |
dc.subject | Folinic acid | en |
dc.subject | Irinotecan | en |
dc.subject | Male | en |
dc.subject | Pathogenesis | en |
dc.subject | Clinical feature | en |
dc.subject | Immunohistochemistry | en |
dc.subject | Cancer grading | en |
dc.subject | Estrogen receptor | en |
dc.subject | Histopathology | en |
dc.subject | Mitomycin c | en |
dc.subject | Progesterone receptor | en |
dc.subject | Lymph node metastasis | en |
dc.subject | Cancer incidence | en |
dc.subject | Prevalence | en |
dc.subject | Brain metastasis | en |
dc.subject | Liver metastasis | en |
dc.subject | Lung metastasis | en |
dc.subject | Ifosfamide | en |
dc.subject | Altretamine | en |
dc.subject | Squamous cell carcinoma | en |
dc.subject | Unknown primary | en |
dc.subject | Undifferentiated carcinoma | en |
dc.subject | Alpha fetoprotein | en |
dc.subject | Physical examination | en |
dc.subject | Prostate specific antigen | en |
dc.subject | Cancer classification | en |
dc.subject | Electron microscopy | en |
dc.subject | Neuroendocrine tumor | en |
dc.subject | Calcitonin | en |
dc.subject | Cervical lymph node | en |
dc.subject | Chromogranin | en |
dc.subject | Synaptophysin | en |
dc.subject | Thyroglobulin | en |
dc.subject | Second cancer | en |
dc.subject | Chorionic gonadotropin | en |
dc.subject | Laboratory test | en |
dc.subject | Neuron specific enolase | en |
dc.subject | Anamnesis | en |
dc.subject | Inguinal lymph node | en |
dc.title | Cancer of unknown primary: Biological and clinical characteristics | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 14 | |
dc.description.issue | SUPPL. 3 | en |
dc.description.startingpage | 11 | |
dc.description.endingpage | 18 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |